SCHMIDT ERIC THOMAS 4
4 · Allogene Therapeutics, Inc. · Filed May 26, 2021
Insider Transaction Report
Form 4
SCHMIDT ERIC THOMAS
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-05-24−14,897→ 94,703 totalExercise: $18.22Exp: 2030-03-18→ Common Stock (14,897 underlying) - Exercise/Conversion
Common Stock
2021-05-24$18.22/sh+14,897$271,423→ 110,994 total
Holdings
- 1,152,595(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.
- [F2]25% of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter.